OI
42
5
WHR
64
3
OKE
81
3
CRM
65
6
FDX
40
4
APH
67
3
CMI
64
5
TXT
52
4
STI
31
-16
CMG
67
3
SRE
66
3
FLS
75
2
HPQ
57
-2
CFG
64
2
ROK
47
-8
ADI
47
2
PAYX
51
4
A
41
5
WEC
55
2
PSA
56
5
OI
42
5
WHR
64
3
OKE
81
3
CRM
65
6
FDX
40
4
APH
67
3
CMI
64
5
TXT
52
4
STI
31
-16
CMG
67
3
SRE
66
3
FLS
75
2
HPQ
57
-2
CFG
64
2
ROK
47
-8
ADI
47
2
PAYX
51
4
A
41
5
WEC
55
2
PSA
56
5
Financhill
Back

Ultragenyx Pharmaceutical Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
28

RARE
Ultragenyx Pharmaceutical

Last Price:
46.00
Seasonality Move:
12.78%
Sell
30

NBY
NovaBay Pharmaceuticals

Last Price:
0.72
Seasonality Move:
-0.57%
Sell
28
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $46.02. The Score for RARE is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.72. The Score for NBY is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $46.02
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.72
    The current trend is relatively stagnant and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.3 Sell
Relative Strength Index (14 RSI): 34.61 Sell
Chaikin Money Flow: -427472 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (47.13 - 53.99) Sell
Bollinger Bands (100): (46.11 - 56.71) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 54.51 Buy
Chaikin Money Flow: 23717 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.61 - 0.75) Buy
Bollinger Bands (100): (0.27 - 1.45) Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 46.28 Sell
20-day SMA: 49.45 Sell
50-day SMA: 53.38 Sell
200-day SMA: 48.05 Sell
8-day EMA: 46.62 Sell
20-day EMA: 48.96 Sell
50-day EMA: 51.25 Sell
200-day EMA: 48.71 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.72 Sell
20-day SMA: 0.7 Buy
50-day SMA: 0.66 Buy
200-day SMA: 2.35 Sell
8-day EMA: 0.71 Buy
20-day EMA: 0.7 Buy
50-day EMA: 0.73 Sell
200-day EMA: 5.62 Sell

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.21 per share, and an increase next year of $1.17 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):